Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Hypotension, Orthostatic

• Treatment of Orthostatic Hypotension in SCI
• Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
• Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
• Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease
• Hypercapnia in Orthostatic Hypotension
• Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
• Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
• Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients
• Lundbeck TOMs Orthostatic Hypotension
• RaGuS Trial by Postoperative Patients
• Efficacy and Tolerance of Flucortac in Patients With Orthostatic Neurogenic Hypotension
• Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
• The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome
• Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
• Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)
• Automated Abdominal Binder for Orthostatic Hypotension
• Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH
• Brain Perfusion & Oxygenation in Parkinson's Disease With NOH
• Effects of Melatonin to Reduce Nocturnal Hypertension in Patients With Neurogenic Orthostatic Hypotension
• Treatment of Post-SCI Hypotension
• Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
• Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
• Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic
• TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
• Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic Failure
• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
• Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
• Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study
• Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI
• An Open Label Trial to Decrease Signs and Symptoms of Orthostatic Hypotension Using Midodrine or Intravenous Fluid Bolus in Patients Following Total Hip Arthroplasty
• Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
• A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
• Efficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip Arthroplasty
• Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients
• Trial Comparing Low Dose and High Dose Steroids in Patients Undergoing Colorectal Surgery
• Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
• Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
• Droxidopa / Pyridostigmine in Orthostatic Hypotension
• Intravenous Norepinephrine for Orthostatic Hypotension
• A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
• Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
• Orthostatic Hypotension Treatment on Rehab Unit
• Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
• Safety and Efficacy of L-NAME and Midodrine to Increase MAP
• A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa
• Fipamezole in Neurogenic Orthostatic Hypotension
• The Pathophysiology of Orthostatic Hypotension
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
• Treatment of Orthostatic Hypotension
• Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
• Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives
• A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
• A Study of Blood Pressure and Blood Supply to the Brain in Persons With a Spinal Cord Injury.
• Treatment of Orthostatic Hypotension in Autonomic Failure
• Orthostatic Hypotension in Rehabilitation Patients
• Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System Atrophy
• A Study for Patients With Neurogenic Orthostatic Hypotension
• A Phase IV Study in Subjects With Neurogenic Orthostatic Hypotension
• Droxidopa in Treating Patients With Neurogenic Hypotension
• Phase II Study of Midodrine for Neurogenic Orthostatic Hypotension